Health
Kimberly-Clark To Acquire Kenvue
By CNBC
Kimberly-Clark said on Monday it will buy Tylenol-maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United States.
Shares of Kenvue were up 18% in premarket tradin ...Read more